Plus Therapeutics Inc PSTV:NASDAQ

RT Quote | Last NYSE Arca, VOL From CTA | USD
after hours iconAfter Hours: Last | 09/17/21 EDT
1.90quote price arrow down-0.07 (-3.55%)
Volume
117,115
Close
1.97quote price arrow up+0.09 (+4.79%)
Volume
1,135,902
52 week range
1.75 - 5.42
Loading...
  • Open1.85
  • Day High1.97
  • Day Low1.81
  • Prev Close1.88
  • 52 Week High5.42
  • 52 Week High Date02/10/21
  • 52 Week Low1.75
  • 52 Week Low Date09/16/21

Key Stats

  • Market Cap30.16M
  • Shares Out15.31M
  • 10 Day Average Volume5.94M
  • Dividend-
  • Dividend Yield-
  • Beta0.37
  • YTD % Change-2.48

KEY STATS

  • Open1.85
  • Day High1.97
  • Day Low1.81
  • Prev Close1.88
  • 52 Week High5.42
  • 52 Week High Date02/10/21
  • 52 Week Low1.75
  • 52 Week Low Date09/16/21
  • Market Cap30.16M
  • Shares Out15.31M
  • 10 Day Average Volume5.94M
  • Dividend-
  • Dividend Yield-
  • Beta0.37
  • YTD % Change-2.48

RATIOS/PROFITABILITY

  • EPS (TTM)-1.64
  • P/E (TTM)-1.20
  • Fwd P/E (NTM)-1.96
  • EBITDA (MRQ)-9.488M
  • ROE (MRQ)-142.15%
  • Revenue (MRQ)0.00
  • Gross Margin (MRQ)20.13%
  • Net Margin (MRQ)-5,337.30%
  • Debt To Equity (MRQ)55.40%

EVENTS

  • Earnings Date10/20/2021
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Plus Therapeutics Inc

There is no recent news for this security.

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
Plus Therapeutics, Inc., is a clinical-stage pharmaceutical company. The Company is focused on developing treatments for patients battling cancer. The Company provides nanotechnology platform to reformulate and improve workhorse chemotherapeutics to provide benefits to patients and healthcare providers. The Company is focused on developing generic oncology drugs that address unmet medical and market needs. The Company’s lead product candidate, DocePLUS, is an...
Richard Hawkins
Chairman
Marc Hedrick M.D.
Chief Executive Officer
Steven Kesten M.D.
President
Andrew Sims CPA
Chief Financial Officer
Desiree Smith CPA
Chief Accounting Officer
Address
4200 Marathon Blvd Ste 200
Austin, TX
78756-3433
United States

Top Peers

SYMBOLLASTCHG%CHG
PBLA
Panbela Therapeutics Inc
2.16-0.14-6.09%
ARTL
Artelo Biosciences Inc
0.85+0.0432+5.35%
PHIO
Phio Pharmaceuticals Corp
2.28+0.10+4.59%
ATXI
Avenue Therapeutics Inc
1.65-0.01-0.60%
BLCM
Bellicum Pharmaceuticals Inc
3.15+0.21+7.14%